| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Laboratory of Chemical Pharmacology and Biometry Section, National Cancer Institute, Bethesda, Md.*)
Multiple treatment with aminopterin and the administration of CF subsequent to treatment with aminopterin both increase the antileukemic specificity of action of aminopterin in mice. A combination of these treatments was shown to be more effective in this respect than either one alone.
* National Institutes of Health, Public Health Service, Department of Health, Education, and Welfare.
Received 8/ 5/54.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |